Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies’ reputations. Litigation has forced the release of internal documents that are shifting the narrative.
(Image credit: Drew Angerer/Getty Images)
Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies’ reputations. Litigation has forced the release of internal documents that are shifting the narrative.
(Image credit: Drew Angerer/Getty Images)